Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis

PURPOSE: Tumor Treating Fields (TTFields) therapy, an electric field-based cancer treatment, became FDA-approved for patients with newly diagnosed glioblastoma (GBM) in 2015 based on the randomized controlled EF-14 study. Subsequent approvals worldwide and increased adoption over time have raised th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballo, Matthew T., Conlon, Patrick, Lavy-Shahaf, Gitit, Kinzel, Adrian, Vymazal, Josef, Rulseh, Aaron M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462574/
https://www.ncbi.nlm.nih.gov/pubmed/37493865
http://dx.doi.org/10.1007/s11060-023-04348-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462574/
https://www.ncbi.nlm.nih.gov/pubmed/37493865
http://dx.doi.org/10.1007/s11060-023-04348-w

Ejemplares similares